Univ. Of Nebraska Board Of Regents Votes To Maintain Current Embryonic Stem Cell Policy
Main Category: Stem Cell ResearchArticle Date: 25 Nov 2009 - 4:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  | |
| Healthcare Prof: | |
The University of Nebraska Board of Regents last week voted 4-4 not to restrict embryonic stem cell research policy beyond current federal and state limits, the New York Times reports. According to the Times, the tie vote defeats a "rare effort" at a university system to curtail stem cell research beyond state and federal law. The decision leaves the school's policy in line with President Obama's guidelines expanding limits on federal funding that can go toward the research.
Groups that oppose embryonic stem cell research considered the vote a new front to fuel national debate on the matter, according to the Times. Supporters and university administrators said the decision will allow the university to continue attracting top researchers and apply for federal grants in the field.
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Visit our stem cell research section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/172120.php>
APA
http://www.medicalnewstoday.com/releases/172120.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
